Iodotrimethylsilane | CAS:16029-98-4

We serve Iodotrimethylsilane CAS:16029-98-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Iodotrimethylsilane
Chemical Name:Iodotrimethylsilane
CAS.NO:16029-98-4
Synonyms:iodo(trimethyl)silane; Trimethyliodosilane; TriMethylsilyl Iodide;
Molecular Formula:C3H9ISi
Molecular Weight:200.09400
 
Physical and Chemical Properties:
Density:1.406;
Boiling point:106oC;
Flash point:1oC;
Index of Refraction:1.471;
 
Specification:
Appearance:Straw liquid
Purity(GC):≥99.0%
 
Packing:280 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can protect or deprotect functional groups selectively, act as silane blocking agent.
It is widely used in the syntheses of drugs.



Contact us for information like Iodotrimethylsilane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TriMethylsilyl Iodid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,TriMethylsilyl Iodid Use and application,Iodotrimethylsilane technical grade,usp/ep/jp grade.


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.L-Ornithine Monohydrochloride manufacturer The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.2,3-Dibromopyridine supplier Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.(3S)-3-(sulfanylmethyl)-1-azabicyclo[2.2.2]octan-3-ol vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.